B

BridGene Biosciences, Inc.

8 employees

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$39M

from 2 investors over 2 rounds

B

BridGene Biosciences, Inc. raised $39M on July 27, 2022

Investors: 厦门德屹股权投资管理有限公司

B

BridGene Biosciences, Inc. raised $12M on May 5, 2021

Investors: Takeda UK Limited

FAQ